IDEAYA Biosciences, Inc. - Common Stock (IDYA)
CUSIP: 45166A102
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,836,000
- Total 13F shares
- 96,817,428
- Share change
- +3,070,396
- Total reported value
- $2,035,216,946
- Put/Call ratio
- 460%
- Price per share
- $21.02
- Number of holders
- 201
- Value change
- +$85,041,555
- Number of buys
- 107
- Number of sells
- 103
Quarterly Holders Quick Answers
What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45166A102:
Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
15%
|
13,130,494
|
$215,077,495 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
8.1%
from 13D/G
|
9,156,517
|
$149,983,748 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
7.3%
|
6,401,781
|
$109,118,775 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.8%
|
5,092,619
|
$83,417,099 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
5.4%
|
4,767,926
|
$78,098,628 | — | 31 Mar 2025 | |
| Logos Global Management LP |
13F
|
Company |
4%
|
3,500,000
|
$57,330,000 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4%
|
3,475,622
|
$56,931,000 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.9%
|
3,446,230
|
$56,449,247 | — | 31 Mar 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
3.7%
|
3,267,551
|
$53,522,485 | — | 31 Mar 2025 | |
| Capital Research Global Investors |
13F
|
Company |
3.1%
|
2,734,923
|
$44,798,039 | — | 31 Mar 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
3%
|
2,622,192
|
$42,951,505 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,079,878
|
$34,075,686 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
2.1%
|
1,838,764
|
$30,118,954 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
1,686,588
|
$27,626,319 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.7%
|
1,505,080
|
$24,653,210 | — | 31 Mar 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.5%
|
1,347,252
|
$22,067,988 | — | 31 Mar 2025 | |
| Fiera Capital Corp |
13F
|
Company |
1.4%
|
1,209,865
|
$19,817,588 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.4%
|
1,188,094
|
$19,460,980 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.3%
|
1,185,186
|
$19,413,348 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.2%
|
1,062,123
|
$17,397,575 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1.1%
|
989,335
|
$16,205,307 | — | 31 Mar 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.1%
|
965,031
|
$15,807,206 | — | 31 Mar 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
1.1%
|
938,177
|
$15,367,427 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.93%
|
816,222
|
$13,369,717 | — | 31 Mar 2025 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
0.9%
|
791,266
|
$12,960,936 | — | 31 Mar 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
771,844
|
$12,642,805 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.86%
|
753,529
|
$12,342,806 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.8%
|
703,716
|
$11,526,868 | — | 31 Mar 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.8%
|
700,000
|
$11,466,000 | — | 31 Mar 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.67%
|
589,330
|
$9,653,225 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.62%
|
547,637
|
$8,970,294 | — | 31 Mar 2025 | |
| Redmile Group, LLC |
13F
|
Company |
0.61%
|
534,600
|
$8,756,748 | — | 31 Mar 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.6%
|
526,688
|
$8,627,151 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.53%
|
468,578
|
$7,675,308 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.53%
|
467,461
|
$7,657,012 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.51%
|
450,147
|
$7,373,408 | — | 31 Mar 2025 | |
| Avidity Partners Management LP |
13F
|
Company |
0.51%
|
445,000
|
$7,289,100 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.5%
|
441,305
|
$7,228,576 | — | 31 Mar 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
0.49%
|
430,161
|
$7,046,037 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.47%
|
413,600
|
$6,774,768 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.41%
|
357,600
|
$5,857,488 | — | 31 Mar 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.38%
|
331,072
|
$5,422,959 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.38%
|
330,593
|
$5,415,112 | — | 31 Mar 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.37%
|
327,644
|
$5,366,809 | — | 31 Mar 2025 | |
| AXA S.A. |
13F
|
Company |
0.37%
|
324,020
|
$5,307,448 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.36%
|
315,372
|
$5,165,793 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.35%
|
308,556
|
$5,054,147 | — | 31 Mar 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.35%
|
306,708
|
$5,024,000 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.35%
|
303,145
|
$4,965,516 | — | 31 Mar 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
293,575
|
$4,808,758 | — | 31 Mar 2025 |
Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q2 2025
As of 30 Jun 2025,
IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by
201 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,817,428 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., Capital Research Global Investors, JANUS HENDERSON GROUP PLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, FEDERATED HERMES, INC., DEERFIELD MANAGEMENT COMPANY, L.P., STATE STREET CORP, and Logos Global Management LP.
This page lists
201
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
204
Q2 2025 holders
201
Holder diff
-3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.